Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160015/S029

AED 3 Defibrillator with Uni-Padz

ZOLL MEDICAL CORPORATION · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP160015/S029

What did the FDA approve?

FDA's database lists P160015/S029 for ZOLL Medical Corporation's AED 3 Defibrillator with Uni-Padz as a normal 180-day-track PMA supplement without user fee, approved 2026-10-16. The supplement reason is postapproval study protocol, and the statement describes approval of a protocol for the post-approval study to replace the original PAS protocol.

Because S029 is a supplement to P160015, it modifies an element of that existing approval rather than approving the device system anew. The statement says the submitted PAS protocol complies with conditions of approval in the P160015/S001 order. It does not report PAS results, so it is not evidence of safety or clinical effectiveness; the replacement protocol's design, endpoints and timeline are absent.

FDA approval order statement

approval of the protocol for the post-approval study (PAS) referenced above to replace the original PAS protocol. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Postapproval Study Protocol

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160015/S029
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160015. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160015 · Original PMA

    AED Plus and Fully Automatic AED Plus

  2. P160015/S024 · Related supplement

    AED Plus and Fully Automatic AED Plus

  3. P160015/S020 · Related supplement

    AED Plus, AED 3, X Series, R Series, Propaq MD, AED Pro, AED 3 BLS

  4. P160015/S029 received

    Application receipt date recorded by FDA.

  5. P160015/S029 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P160015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160015

Product / regulatory recordCompanyPathwayDecision dateSource
ZOLL MEDICAL CORPORATIONPMA approvalMay 26, 2017FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 24, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementAug 28, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 22, 2025FDA
AED 3P160015/S025
ZOLL MEDICAL CORPORATIONPMA supplementDec 18, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 16, 2026FDA

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ZOLL MEDICAL CORPORATION

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
269 & 271 Mill Rd., Chelsmford, MA, 01824

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records